Proteins from the 18 glycosyl hydrolase family are associated with kidney dysfunction in patients with diabetes type 2

Biomarkers

Volumn 20, Issue 1, 2015, Pages 52-57

  Zurawska Plłaksej, Ewa ^a   Lługowska, Agnieszka ^b   Hetmańczyk, Katarzyna ^b   Knapik Kordecka, Maria ^a   Adamiec, Rajmund ^a   Piwowar, Agnieszka ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

Albuminuria; Biomarker; Chitotriosidase; Diabetes mellitus; Diabetic nephropathy; YKL 40

Indexed keywords

BIOLOGICAL MARKER; CHITINASE 3 LIKE PROTEIN 1; CHITOTRIOSIDASE; GLYCOSIDASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ORAL ANTIDIABETIC AGENT; UNCLASSIFIED DRUG; ADIPOCYTOKINE; BETA N ACETYLHEXOSAMINIDASE; CHI3L1 PROTEIN, HUMAN; LECTIN;

ADULT; ALBUMINURIA; ARTICLE; CLINICAL EVALUATION; CLINICAL LABORATORY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; HUMAN; KIDNEY DYSFUNCTION; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; PROTEIN FAMILY; AGED; BLOOD; CASE CONTROL STUDY; ENZYMOLOGY;

ADIPOKINES; AGED; ALBUMINURIA; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HEXOSAMINIDASES; HUMANS; LECTINS; MALE; MIDDLE AGED;

EID: 84921813224     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2014.992475     Document Type: Article

References (37)

1. Akcay A, Nguyen Q, Edelstein CL. (2009). Mediators of inflammation in acute kidney injury. Mediators Inflamm 2009:137072. doi:10.1155/2009/137072.
2. Artieda M, Cenarro A, Gañán A, et al. (2003). Serum chitotriosidase activity is increased in subjects with atherosclerosis disease. Arterioscler Thromb Vasc Biol 23:1645-52.
3. Aydogdu A, Tasci I, Tapan S, et al. (2012).Women with polycystic ovary syndrome have increased plasma chitotriosidase activity: a pathophysiological link between inflammation and impaired insulin sensitivity? Exp Clin Endocrinol Diabetes 120:261-5
4. Aziz M, Wissing ML, Naver KV, et al. (2014). Polycystic ovary syndrome and low-grade inflammation with special reference to YKL- 40. Gynecol Endocrinol 30:311-15.
5. Boot RG, Renkema GH, Verhoek M, et al. (1998). The human chitotriosidase gene. Nature of inherited enzyme deficiency. J Biol Chem 273:25680-5.
6. Boot RG, van Achterberg TA, van Aken BE, et al. (1999). Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages. Arterioscler Thromb Vasc Biol 19:687-94.
7. Duran-Salgado MB, Rubio-Guerra AF. (2014). Diabetic nephropathy and inflammation. World J Diabetes 5:393-8.
8. Eleftheriadis T, Antoniadi G, Pissas G, et al. (2013). The renal endothelium in diabetic nephropathy. Ren Fail 35:592-9.
9. Helger R, Rindfrey H, Hilgenfeldt J. (1974). [Direct estimation of creatinine in serum and in urine without deproteinization using a modified Jaffé method]. Z Klin Chem Klin Biochem 12:344-9.
10. Hollak CE, van Weely S, van Oers MH, Aerts JM. (1994). Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Invest 93:1288-92.
11. Hussain M, Wilson JB. (2013). New paralogues and revised time line in the expansion of the vertebrate GH18 family. J Mol Evol 76:240-60.
12. Johansen JS. (2006). Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. Dan Med Bull 53:172-209.
13. Kanneganti M, Kamba A, Mizoguchi E. (2012). Role of chitotriosidase (chitinase 1) under normal and disease conditions. J Epithel Biol Pharmacol 5:1-9.
14. Kim HM, Lee BW, Song YM, et al. (2012). Potential association between coronary artery disease and the inflammatory biomarker YKL-40 in asymptomatic patients with type 2 diabetes mellitus. Cardiovasc Diabetol 11:84. doi:10.1155/2009/137072.
15. Kolset SO, Reinholt FP, Jenssen T. (2012). Diabetic nephropathy and extracellular matrix. J Histochem Cytoche. 60:976-86.
16. Kundak AA, Tascilar ME, Abaci A, et al. (2012). Serum chitotriosidase activity: is it a new inflammatory marker in obese children? J Pediatr Endocrinol Metab 25:63-7
17. Levey AS, Bosch JP, Lewis JB, et al. (1999). A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461-70.
18. MacIsaac RJ, Ekinci EI, Jerums G. (2014). 'Progressive diabetic nephropathy. How useful is microalbuminuria?: contra'. Kidney Int 86:50-7.
19. Miralles JM, Corrales JJ, Garcia-Diez LC, et al. (1982). N-acetyl beta-Dglucosaminidase and alpha-L-fucosidase activities in relation to glycosylated hemoglobin levels and to retinopathy in diabetes. Clin Chim Acta 121:373-8.
20. Nakagawa T, Tanabe K, Croker BP, et al. (2011). Endothelial dysfunction as a potential contributor in diabetic nephropathy. Nat Rev Nephrol 7:36-44.
21. Nishikawa KC, Millis AJ. (2003). gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells. Exp Cell Res 287:79-87.
22. Piwowar A, Knapik-Kordecka M, Warwas M. (2008). Oxidative stress and endothelium dysfunction in diabetes mellitus type 2. Pol Merkur Lekarski 25:120-3.
23. Polovina MM, Potpara TS. (2014). Endothelial dysfunction in metabolic and vascular disorders. Postgrad Med 126:38-53.
24. Rathcke CN, Persson F, Tarnow L, et al. (2009). YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria. Diabetes Care 32:323-8.
25. Rathcke CN, Vestergaard H. (2006). YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis. Inflamm Res 55:221-7.
26. Recomendation of the Polish Society of Diabetology. (2012). Clinical guidelines for management of diabetes. Diabetol Klin 1:A1-54.
27. Riabov V, Gudima A, Wang N, et al. (2014). Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis. Front Physiol 5:75. doi:10.3389/fphys.2014.00075.
28. Roøndbjerg AK, Omerovic E, Vestergaard H. (2011). YKL-40 levels are independently associated with albuminuria in type 2 diabetes. Cardiovasc Diabetol 10:54. doi:10.1186/1475-2840-10-54.
29. Roshan B, Stanton RC. (2013). A story of microalbuminuria and diabetic nephropathy. J Nephropathol 2:234-40.
30. Schosinsky KH, Vargas M, Luz Esquivel A, Chavarria MA. (1987). Simple spectrophotometric determination of urinary albumin by dyebinding with use of bromphenol blue. Clin Chem 33:223-26.
31. Sonmez A, Haymana C, Tapan S, et al. (2010). Chitotriosidase activity predicts endothelial dysfunction in type-2 diabetes mellitus. Endocrine 37:455-9.
32. Sun YM, Su Y, Li J, Wang LF. (2013). Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy. Biochem Biophys Res Commun 433:359-61.
33. Tao H, Yang JJ, Shi KH, et al. (2014). The significance of YKL-40 protein in liver fibrosis. Inflamm Res 63:249-54.
34. van Eijk M, van Roomen CP, Renkema GH, et al. (2005). Characterization of human phagocyte-derived chitotriosidase, a component of innate immunity. Int Immunol 17:1505-12.
35. Wiela-Hojeńska A, Orzechowska-Juzwenko K. (1999). N-acetyl-beta-Dglucosaminidase and its clinical significance. Pol Arch Med Wewn 101:359-66.
36. Yildiz BS, Barutcuoglu B, Alihanoglu YI, et al. (2013). Serum chitotriosidase activity in acute coronary syndrome. J Atheroscler Thromb 20:134-41.
37. Żurawska-Płaksej E, Rorbach-Dolata A, Knapik-Kordecka M, Piwowar A. (in press). Increased chitotriosidase activity in plasma with diabetes type 2. Arch Med Sci.